2013
DOI: 10.1016/j.psyneuen.2012.11.019
|View full text |Cite
|
Sign up to set email alerts
|

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
255
0
14

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 323 publications
(276 citation statements)
references
References 92 publications
7
255
0
14
Order By: Relevance
“…Almost all of the studies testing emotion recognition in healthy samples have administered the standard dose of 24 IU. Systematic evaluation of how response changes according to dose and other measurable factors that influence bioavailability of nasal administration is required (Guastella et al, 2013). These changes should be evaluated in the context of a range of other variables thought to mark response to OT, such as heart rate variability (Kemp et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Almost all of the studies testing emotion recognition in healthy samples have administered the standard dose of 24 IU. Systematic evaluation of how response changes according to dose and other measurable factors that influence bioavailability of nasal administration is required (Guastella et al, 2013). These changes should be evaluated in the context of a range of other variables thought to mark response to OT, such as heart rate variability (Kemp et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Twenty-four International Units is the most common dosage because of historical reasons; however, it is unclear whether other more optimal doses exist or whether someone who does not respond to lower doses will respond to higher ones (see Guastella et al, 2013) with respect to the latest recommendations relating to nasal spray administration).…”
Section: Types Of Interventionmentioning
confidence: 99%
“…53), elevated oxytocin in CSF is likely to reflect transnasal penetration into the CNS (4, 52), verifying that nebulization of oxytocin was successful. Unlike other routes of administration (e. g., intranasal, intravenous), nebulizing oxytocin may allow oxytocin molecules to be absorbed into the CNS through the nasal mucosa (54,55), making it one of the most effective routes of administration (50). Elevated oxytocin levels in both the CNS and periphery are most likely due to the direct effects of exogenous peptide administration, although it is impossible to rule out a contribution from endogenous oxytocin release (50).…”
Section: Discussionmentioning
confidence: 99%
“…In line with recommendations by Guastella et al (2013), the nasal spray was administered via a metered multi-dose pump spray bottle, with each spray containing no N 100 μL. Participants were given the opportunity to blow their nose prior to administration in order to clear the nasal passage if needed.…”
Section: Arrival and Nasal Spray Administrationmentioning
confidence: 99%
“…Intranasal administration has been proposed to deliver OT to the brain via uptake by the olfactory or trigeminal nerves and by passive diffusion into the cerebrospinal fluid through the nasal epithelium (for detailed reviews see Churchland and Winkielman, 2012;Guastella et al, 2013;Veening and Oliver, 2013). Intranasal OT has been demonstrated to lead to significant increases in CSF OT levels in humans as measured by lumbar puncture (Striepens et al, 2013), although it was only detectable 75 min after administration and there is controversy surrounding the nature and the mechanisms of the effects of OT administration on the brain (Leng and Ludwig, 2015).…”
Section: Arrival and Nasal Spray Administrationmentioning
confidence: 99%